In this model, a significant trend was observed with number of years of prior non-glargine insulin exposure ( p -trend = 0.02, HR = 1.24, 95% CI 1.03–1.50 per additional year of exposure, Model 2) (not shown).
← all excerpts
Insulin glargine use and breast cancer risk: Associations with cumulative exposure.
1
—
—